| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.21 | 1e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.09 | 0.1 |